Sponsors

Stallergenes Greer is a fully integrated global biopharmaceutical company specialising in the research, diagnosis, and treatment of allergies through the development and commercialisation of allergen immunotherapy (AIT) products and services.

Through our extensive product portfolio, available in multiple formulations (subcutaneous, sublingual drops and tablets for respiratory and food allergies), we thrive on reaching our purpose to enable precision medicine to improve life for people with allergies.

As a world leader in allergen immunotherapy, we constantly aim at delivering sustainable value to all our stakeholders i.e., our patients, the medical community, healthcare systems, colleagues, and our shareholder. To achieve our ambitious objective, we are focusing our efforts on four pillars:

• excellence in execution: to serve patients with high-quality products and optimal solutions to treat allergies thanks to a robust supply chain and state-of-the-art pharmaceutical technologies,
• strengthening our core business: expanding our geographical footprint to reach more patients in need of precise, personalised treatments, by offering the broadest portfolio of allergens and delivery systems.
• developing new solutions for patients: for the benefit of patients across the globe, through the generation of the evidence of our treatments with new clinical and real-world data,
• attracting and developing talents: investing in the development of our colleagues, committed to improving the quality of life of allergy sufferers.

Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.

Menarini Asia-Pacific is a member of the Menarini Group, a leading international pharmaceutical and diagnostic company with a heritage of over 135 years and over 17,000 employees in 140 countries. Here in Asia-Pacific, Menarini’s vision is to be a leading provider of important healthcare brands to improve the lives of people. Menarini Asia-Pacific operates across the entire commercial value chain, from clinical development, regulatory approval, and product launch to lifecycle management with a diverse portfolio of proprietary and partnered brands in key therapeutic fields, including Consumer Health, Dermatology, Allergy/Respiratory, Gastroenterology, Cardio-metabolic, Anti-infectives, Oncology/Specialty Care and Men’s Health.

Who we are

GSK is a focused biopharma company with strong momentum and big ambitions, to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

What we do

We prioritise innovation in vaccines and specialty medicines to prevent and treat disease. At the heart of this is our R&D focus on the science of the immune system, human genetics and advanced technologies, and our world-leading capabilities in vaccines and medicines development. We focus on four core therapeutic areas: infectious disease, HIV, respiratory/immunology, and oncology.

Our Portfolio

Vaccines: Our broad vaccines portfolio targets infectious diseases at every stage of life helping protect people from shingles, respiratory syncytial virus, meningitis, flu, polio, measles and many more.

Specialty Medicines: Our portfolio of specialty medicine prevents and treat diseases, from HIV to respiratory diseases, immune-mediated conditions like lupus, and cancer. Many are first or best-in-class. Our specialty medicine is focused on four therapeuctic areas: infectious disease, HIV, respiratory/ immunology and oncology.

General Medicines: From inhaled medicines for asthma and COPD to antibiotics to medicines for skin diseases, we make life better for millions of people in over 112 countries worldwide.

For more information, please visit: www.gsk.com

Sanofi: Chasing Miracles to Transform Lives
At Sanofi, we unite under a shared purpose: to chase the miracles of science and improve lives worldwide. With determination and cutting-edge innovation, we’re redefining the boundaries of medicine, delivering breakthrough treatments and vaccines to patients in need.

From our roots as a local French enterprise to our standing as a global healthcare leader, reinvention has always been in our DNA. Guided by our ambition to transform healthcare, we leverage advanced science, state-of-the-art manufacturing, and the power of data and digital technologies to achieve what once seemed impossible.

Progress is our driving force. It inspires us to push boundaries, learn continuously, and challenge the status quo. Together, we strive to make a lasting impact on patients, communities, and our colleagues—creating a better future for all.

Abbott Laboratories (M) Sdn Bhd, headquartered in Petaling Jaya, Selangor, has been dedicated to advancing health in Malaysia since 1987. With over 1,900 employees, Abbott offers a diverse range of science-based nutritional products, pharmaceuticals, diagnostic tools, and vascular devices, aiming to improve the quality of life for people across Malaysia.

AstraZeneca We are a global, science-led, patient-focused pharmaceutical company. We are dedicated to transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet.

At Beckman Coulter, we are dedicated to advancing and optimizing the laboratory. For more than 80 years, we have been a trusted partner for laboratory professionals, helping to advance scientific research and patient care. We have a vital role: our focus on innovation, reliability and efficiency has led us to become the partner of choice for clinical, research and industrial customers around the globe.

Beckman Coulter Life Sciences delivers innovative and trusted scientific solutions across the globe for laboratory customers in a wide variety of settings: universities, government, biotechnology and pharmaceutical companies, hospitals, and commercial laboratories. By innovating new processes and technologies, we’re challenging conventional wisdom to develop the best, most widely trusted laboratory solutions available in the market today.

We know how to help accelerate breakthroughs in scientific research. We know how you can capture the precise information you need to improve product quality. We can help you get the data you need, when you need it, to succeed at whatever pursuit you’ve devoted your life to.

We’ve devoted ours to advancing science through discovery.

Please visit Beckman.com if you'd like to know more.

Malaysia offers comprehensive market coverage, serving over 170 clients and thousands of customers nationwide. DKSH’s mission is to help other companies and brands grow their business in new or existing markets. Its business activities are being organized into four specialized Business Units which include Consumer Goods, Healthcare, Performance Materials, and Technology.

QV Skincare is a true home-grown success story. Built on a foundation of hard work and innovative thinking, the gentle, scientific formulations of our brand have seen us rise from humble origins to become one of Australia’s favourite and most trusted skincare brands, for dry or sensitive skin.

QV Skincare began as the brainchild of Ego Pharmaceuticals (or simply Ego), founded in 1953 by young chemist Gerald Oppenheim and his wife, Rae, a nurse.

It was in response to a request from the dermatology ward of Melbourne’s iconic Queen Victoria Hospital that Gerald Oppenheim created a specialist skincare product that would later become known as QV Bath Oil – named in honour of the hospital, QV = Queen Victoria.

Favoured for its gentle formula, QV Bath Oil became extremely popular. Three short years later, it was made available in pharmacies, establishing the QV name in the minds (and hearts) of Australians looking for a gentle range skincare to cleanse and moisturise dry and sensitive skin. This product continues to garner broad interest from consumers until today.

Elcomed Sdn Bhd was incorporated in Malaysia in October, 2018. The current business activities include marketing, sales and servicing of Agnitio Science & Technology, Taiwan - Agnitio BioIC Allergy Testing System. Elcomed Sdn Bhd is playing an important role in local allergy testing market with Installation in more than 20 hospital & commercial laboratories nationwide. In 2024, Elcomed Sdn Bhd has emerged to become the country No.1 allergy test provider with the largest number of tests done.

Hyphens Pharma focuses on the sales and marketing of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States.

Hyphens Dermatology is a strategic business unit of Hyphens, committed to offering innovative medical dermatological products, to meet the needs of patients suffering from various skin disorders. We have deep expertise in Acne, Atopic Dermatitis, Ageing, Hyperpigmentation and Hair Loss.

At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world's best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world's premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, Pfizer has worked to make a difference for all who rely on us.

BioLegend creates world-class, cutting-edge antibodies and reagents across a diverse set of applications—from flow cytometry to immunoassays to multiomics.
We’re accelerating research and discovery by providing high-quality, purpose-driven products for outstanding value. With 30,000 trusted reagents, 100,000+ citations in peer-reviewed publications, and a dedicated team to create custom solutions for your lab, there’s nothing our expertise doesn’t cover. Discover the BioLegend difference and see how it can make an impact in your lab. Learn more at bioLegend.com

MADx - Macro Array Diagnostics Founded in 2016, MADx has established itself as a leading developer and manufacturer of high-precision allergy and food intolerance tests. The product range serves laboratories, medical practices, hospitals, and allergy centres worldwide. The company's focus is on the development of pioneering, intuitive immunodiagnostic solutions at the molecular level. With a presence in over 80 countries worldwide, the visionary MADx stands for dynamism, quality, and the promise of constantly pushing the boundaries of diagnostics in the field of allergy and food intolerance.

ZP Therapeutics, a division of Zuellig Pharma, is the commercialization partner of choice for the healthcare industry, with offices in 13 countries across Asia and over 2,500 associates. We are a catalyst in improving patient journeys and healthcare outcomes through commercial excellence, robust in-market capabilities, and strong ethical principles. Our commitment to making healthcare accessible is fueled by agility, resilience, integrity, and passion for excellence in everything we do.

HOE Pharmaceuticals was founded in Malaysia in 1979 and was acquired by Taisho Pharmaceutical Group in 2011, the number one OTC Pharmaceutical company in Japan.

We offer an extensive range of products including prescription drugs (generic & innovative), specializing in the areas of Dermatology, Diabetic, Orthopedic, Respiratory and OTC (for Health and Beauty).